Arvinas, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ARVN Nasdaq 2834 www.arvinas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arvinas, Inc.

RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure - Jul 18th, 2025 9:28 am
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - Jul 17th, 2025 8:02 am
Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag - Jul 16th, 2025 9:54 am
Arvinas Presents Promising Preclinical Data for BCL6 Degrader ARV-393 in Lymphoma Treatment - Jul 15th, 2025 6:59 am
FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks - Jul 14th, 2025 9:33 am
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan - Jul 9th, 2025 5:00 am
Wall Street Analysts Believe Arvinas (ARVN) Could Rally 89.85%: Here's is How to Trade - Jun 16th, 2025 7:55 am
Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress - Jun 13th, 2025 5:00 am
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer - Jun 6th, 2025 5:00 am
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the 2025 European Hematology Association (EHA) Annual Meeting - Jun 5th, 2025 6:28 am
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer - May 31st, 2025 6:00 am
Does Arvinas (ARVN) Have the Potential to Rally 94.93% as Wall Street Analysts Expect? - May 30th, 2025 7:55 am
Arvinas to Present at Jefferies Global Healthcare Conference - May 30th, 2025 5:00 am
Pfizer and Arvinas gamble to shift breast cancer treatment paradigm - May 29th, 2025 8:29 am
Arvinas, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - May 4th, 2025 6:36 am
Here are 1 Main Capital Partners’ Views on Arvinas (ARVN) - May 2nd, 2025 7:19 am
Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... - May 2nd, 2025 1:03 am
Arvinas, Inc. (ARVN) Q1 Earnings and Revenues Beat Estimates - May 1st, 2025 6:15 am
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 1st, 2025 5:00 am
Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Apr 29th, 2025 8:01 am